Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × Long-Term Synaptic Depression × Clear all

NCT05637268 2022-12-05

Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms